· Periodic Report
Q3 operating loss of KRW 3.7 billion on revenue of KRW 25 million
Quadmedicine sold KRW 25 million in Q3 and lost KRW 3.7 billion from its main business, versus sales of KRW 1.9 billion and a loss of KRW 2.6 billion a year earlier.
464490 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Quadmedicine sold KRW 25 million in Q3 and lost KRW 3.7 billion from its main business, versus sales of KRW 1.9 billion and a loss of KRW 2.6 billion a year earlier.
Get app alerts for new disclosures from QuadMedicine Inc..